Phreesia (PHR) Stock Forecast: StockMap's 2-Week Call
PHR stock forecast: StockMap's model makes no two-week call on Phreesia after the Nov 13 close: its evidence is split, 3 reasons for and 12 against. Right in 2 of 3 two-week windows on PHR since Sep 24; by chance, a call on the same dates was right 66% of the time.
Phreesia last closed at $12.69, +0.55% on the session.
Against the IVW growth benchmark the position is +1.46% over the forecast window.
Phreesia's market cap is $787.64M as of November 13, 2026.
No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is 1 (too close to call).
Where PHR sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 3 bullish and 12 bearish.
Agreement across those insights is 20%.
11 daily calls for PHR so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Phreesia in the 8th percentile on valuation and the 44th percentile on return on equity, where 100 is best.
Phreesia is classified under Health Care / Health Care Technology.
StockMap tracks Phreesia as the 10th largest of the 21 companies it covers in the Health Care Technology industry, part of the Health Care sector.
Across that group the current two-week reads are 14 Neutral, 3 Strong Underperform, 2 Moderate Outperform and 2 Moderate Underperform.
On that composite Phreesia ranks 11th of 21 in the group, against a group median of +0.01.